KRW 6560.0
(-4.51%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 1.48 Billion KRW | 1057.2% |
2022 | 128.59 Million KRW | 56.19% |
2021 | 82.33 Million KRW | -46.07% |
2020 | 152.66 Million KRW | 0.0% |
2019 | - KRW | 0.0% |
2018 | - KRW | 0.0% |
2017 | - KRW | 0.0% |
2016 | - KRW | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 1.34 Billion KRW | 0.0% |
2024 Q2 | - KRW | -100.0% |
2023 Q4 | 1.48 Billion KRW | -5.66% |
2023 FY | 1.48 Billion KRW | 1057.2% |
2023 Q3 | 1.57 Billion KRW | -3.71% |
2023 Q2 | 1.63 Billion KRW | 2193.44% |
2023 Q1 | 71.43 Million KRW | 0.0% |
2022 Q2 | - KRW | 0.0% |
2022 Q1 | - KRW | 0.0% |
2022 Q3 | - KRW | 0.0% |
2022 Q4 | - KRW | 0.0% |
2021 Q4 | - KRW | -100.0% |
2021 Q3 | 5 Billion KRW | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Osang Healthcare Co.,Ltd | 367.49 Million KRW | -304.947% |
InBody Co.,Ltd | 3.63 Billion KRW | 59.074% |
Seegene, Inc. | 1.42 Billion KRW | -4.546% |
i-SENS, Inc. | 45.74 Billion KRW | 96.747% |
Ray Co., Ltd. | 155.4 Million KRW | -857.62% |
Gencurix Inc. | 5.47 Billion KRW | 72.825% |
Sugentech Inc. | 240 Million KRW | -520.059% |
L&C Bio Co., Ltd | 541.32 Million KRW | -174.91% |